Search results for:
Ondine President Presents at RSM Photodynamic Therapy Symposium
Ondine’s President and CTO, Dr. Nicolas Loebel Presented at The Royal Society of Medicine (RSM) Photodynamic Therapy Symposium (London, England) VANCOUVER, BC – December 5, 2018 On Monday, November 26, 2018 Dr. Nicolas Loebel, President and Chief Technology Officer of Ondine [...]
Ondine Launches SurgENT™ for U.S. Chronic Sinus Sufferers
Ondine Biomedical Inc. Launches SurgENT™ for U.S. Chronic Sinus Sufferers VANCOUVER, BC, CANADA AND ATLANTA, GA - October 9, 2018 SurgENT™ was officially launched during the 64th Annual Meeting of the American Rhinologic Society in Atlanta, GA Ondine Biomedical, Inc., an [...]
FDA Grants QIDP Designation to Ondine for Nasal Photodisinfection System
FDA Grants “Qualified Infectious Disease Product” (QIDP) Designation to Ondine Biomedical Inc. Subsidiary for Their Nasal Photodisinfection System VANCOUVER, BC – October 03, 2018 The FDA designation provides five years of additional market exclusivity after approval for Ondine Biomedical Inc.’s nasal [...]
New Book By Advisory Member: The Human Microbiota in Health and Disease
New Book By Advisory Member: The Human Microbiota in Health and Disease VANCOUVER, BC – September 21, 2018 Ondine Biomedical Inc. congratulates its Medical Advisory Board member, Dr. Michael Wilson, emeritus Professor of Microbiology at University College London, on the release [...]
Two Canadian Companies Join Forces for Chronic Sinus Sufferers
Two Canadian companies join forces to bring Medical Innovation to Canada’s Chronic Sinus Sufferers VANCOUVER, BC – September 17, 2018 Ondine Biomedical, Inc., an innovative medical solutions company, today announced that they have entered into an exclusive agreement with Southmedic, Inc., [...]
The Honourable Jean Charest Appointed to Ondine Board of Directors
Ondine Biomedical Announces the Appointment of The Honourable Jean Charest, Former Premier of Quebec and Deputy Prime Minister of Canada to Board of Directors VANCOUVER, BC – Feb. 12, 2018 Mr. Charest is currently a partner in the law firm McCarthy [...]
Superbugs No Match for Photodisinfection Technology
Press Conference: Superbugs No Match for Ondine’s Photodisinfection Technology VANCOUVER, BC – January 31, 2018 Ondine Biomedical Inc. is set to announce a major advancement in the treatment and prevention of multi-drug resistant infections in healthcare facilities during a press conference [...]
Ondine Donates to FOCOS Orthopaedic Hospital
Ondine Biomedical Group Donates to FOCOS Orthopaedic Hospital VANCOUVER, BC – July 12, 2017 Founder and CEO of FOCOS Orthopaedic Hospital, Prof Boachie-Adjei was invited to Vancouver Canada to visit the Ondine Biomedical Group, pioneers of photodynamic therapy. Carolyn Cross, CEO [...]
Dr. Nicolas Loebel Receives IPA Clinical PDT Research Excellence Award
Dr. Nicolas Loebel Receives the 2017 IPA Clinical PDT Research Excellence Award COIMBRA, Portugal - June 26, 2017 At the 16th International Photodynamic Association (IPA) World Congress in Coimbra, Dr. Nicolas Loebel was the recipient of the 2017 CLINICAL PDT RESEARCH EXCELLENCE AWARD. Dr. Loebel is [...]
For Media Information
Simon Vane Percy
Amanda Bernard
